Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center

The Curtis and Elizabeth Anderson Cancer Institute (ACI) at Memorial University Medical Center, is a cancer center in Savannah, Georgia. Memorial Health is accredited by the Commission on Cancer of the American College of Surgeons as a Teaching Hospital Cancer Program. The center is a recipient of the Georgia Cancer Coalition Distinguished Cancer Scholars Award, which supports leaders who are engaged in the most promising areas of cancer research. Memorial Health is a member of the Georgia CORE Research Network, a statewide network of academic and community-based oncologists and researchers and a member of the Georgia CORE Gynecologic Oncology Group Consortium. The center consists of 32 physicians, including two radiation oncologists. Memorial Health offers a state-of-the-art research laboratory, leading-edge technology and compassionate support programs. They offer the following services: community support groups, educational programs, insurance assistance, resource room, oncology interdisciplinary care, coordination team, oncology social workers, patient advocacy, support line, wellness services, spiritual care and pediatric services.

Treatment Sites in Georgia

Clinical Trials in Georgia

Data and Specimen Registry of Patients With Rare or Cutaneous Non-Hodgkin Lymphoma
Cancer Type: Lymphoma

A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (NSC# 102816) to Chemotherapy in Infants with Acute Lymphoblastic Leukemia (ALL) and KMT2A(MLL) Gene Rearrangement
Cancer Type: Acute Lymphoblastic Leukemia

A Multi-center, Open Label, Non-controlled Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Pediatric Patients With Newly Diagnosed Ph+ Chronic Myelogenous Leukemia (CML) in Chronic Phase (CP) or With Ph+ CML in CP or Accelerated Phase (AP) Resistant or Intolerant to Either Imatinib or Dasatinib
Cancer Type: Leukemia

A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T- Lymphoblastic Leukemia (T-ALL) and T- Lymphoblastic Lymphoma (T-LLy)
Cancer Type: Leukemia

A Randomized Double-Blind Phase 3 Trial Comparing EC145 and Pegylated Liposomal Doxorubicin (PLD/Doxil®/Caelyx®) in Combination Versus PLD in Participants With Platinum-Resistant Ovarian Cancer
Cancer Type: Ovarian Cancer

A Randomized Phase II Trial of Intermittent Versus Continuous Dosing of Dabrafenib (NSC-763760) and Trametinib (NSC-763093) in BRAF V600E/K Mutant Melanoma
Cancer Type: Melanoma

A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
Cancer Type: Breast Cancer

Biological Specimen Collection and Banking From Patients With Ewing Sarcoma
Cancer Type: Ewing Sarcoma

National Wilm's Tumor Study Late Effects
Cancer Type: Wilms Tumor

Pazopanib Neoadjuvant Trial in Non-rhabdomyosarcoma Soft Tissue Sarcomas (PAZNTIS): A Phase II/III Randomized Trial of Preoperative Chemoradiation or Preoperative Radiation Plus or Minus Pazopanib (NSC# 737754)
Cancer Type: Bone and Soft Tissue (including Sarcoma)

Phase II Randomized Study of Pelvic Radiotherapy With Versus Without Cisplatin in Patients With Recurrent Endometrial Cancer
Cancer Type: Endometrial Cancer

Phase III Randomized Study of Adjuvant Chemotherapy Comprising Carboplatin and Paclitaxel With Versus Without Bevacizumab and/or Secondary Cytoreduction Surgery in Patients With Platinum-Sensitive Recurrent Ovarian Epithelial Cancer, Primary Peritoneal
Cancer Type: Ovarian Cancer

Phase III Randomized Study of Adjuvant Gemcitabine Hydrochloride With Versus Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With Versus Without Chemoradiotherapy With Either Capecitabine or Fluorouracil in Patients With Resected
Cancer Type: Pancreatic Cancer

Phase III Randomized Study of Adjuvant Intensity-Modulated Radiotherapy With Versus Without Cetuximab in Patients With Locally Advanced Resected Squamous Cell Carcinoma of the Head and Neck
Cancer Type: Head and Neck Cancer

Phase III Randomized Study of Adjuvant Radiation Versus Chemoradiation Therapy in Patients With Intermediate-Risk Stage I-IIA Cervical Cancer Treated With Initial Radical Hysterectomy and Pelvic Lymphadenectomy
Cancer Type: Cervical Cancer

Phase III Randomized Study of Methotrexate Versus Dactinomycin in Patients With Low-Risk Gestational Trophoblastic Neoplasia
Cancer Type: Unknown Primary

Phase III Randomized Study of Standard Chemoradiotherapy With or Without Carboplatin Followed by Standard Maintenance Therapy With or Without Isotretinoin and Continuation Therapy With Isotretinoin Versus No Continuation Therapy in Pediatric Patients Wit
Cancer Type: Brain Cancer

Phase III Randomized Study of Three Different Thoracic Radiotherapy Regimens in Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
Cancer Type: Lung Cancer

Phase III Study of Combination Chemotherapy in Pediatric Patients With Newly Diagnosed Hepatoblastoma
Cancer Type: Liver Cancer

Pilot Study of Neuropsychological and Behavioral Assessment in Children With Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor (PNET)
Cancer Type: Brain Cancer

Repository Study of Blood and Tumor Tissue Samples From Patients With Osteosarcoma
Cancer Type: Bone and Soft Tissue (including Sarcoma)

Research Study of Clinical, Genetic, and Biological Factors as Prognostic Values in Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
Cancer Type: Neuroblastoma

Study of Collection and Banking of Malignant, Borderline Malignant Neoplasms, and Related Biological Specimens from Young Patients With Cancer
Cancer Type: Leukemia

Study of Renal Tumors in Pediatric Patients
Cancer Type: Kidney Cancer

Study to Collect and Characterize Tissue Specimens From Patients With Rhabdomyosarcoma Or Non-Rhabdomyosarcoma Soft Tissue Sarcoma
Cancer Type: Bone and Soft Tissue (including Sarcoma)

Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-high-Risk Neuroblastoma: A Groupwide Historically Controlled Phase III Study
Cancer Type: Neuroblastoma